Aug
2026
COEX, Seoul, Korea
Visit us
stand PB28

CordenPharma International GmbH

Exhibitor at CPHI Korea 2026
About Us

CordenPharma is a CDMO partner supporting biotech and pharma innovators of complex modalities in the advancement of their drug development lifecycle, providing bespoke outsourcing services spanning the complete supply chain, from early clinical-phase development to commercialization. With scientific expertise and partnership at its core, we provide customers high-value, end-to-end services with strategic focus on Peptides, Oligonucleotides, customized Lipid Excipients, Lipid NanoParticles, sterile Injectables and the extensive supply of Small Molecules (Highly Potent and Regular Potency).

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Germany
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Korea 2026
  • 25 Aug 2026 - 27 Aug 2026
  • COEX, Seoul, Korea
  • Visit us at stand PB28

Products Featured at CPHI Korea 2026

  • API Crystallization Capabilities & Services

    Product API Crystallization Capabilities & Services

    Identifying, developing, and obtaining the best crystalline form of an API is crucial in drug development. It has a significant impact on the drug product quality, the effectiveness of the drug product formulation and, in particular, the bioavailability of the finished dosage form. At CordenPharma we have ...
  • Bioavailability Enhancement

    Product Bioavailability Enhancement

    Solubility is one of the key attributes of a drug candidate and one of the biggest challenges in drug development. Approximately 70-90% of New Molecular Entities (NMEs) in today’s drug pipeline are poorly soluble, which complicates delivery, resulting in poor bioavailability. The majority of these NMEs are...
  • CordenPharma Oligonucleotides Platform

    Product CordenPharma Oligonucleotides Platform

    Your Expert Partner for Oligonucleotide APIs - Process Development & Small-scale: scale-up to 10 mmol per run (small-scale equipment can also support early-stage supply) - Scale-up & Small to Medium-scale: scale-up to 100 mmol per run (supported by OligoPilotTM equipment) - Large-Scale Oligonucleotide Proc...
  • CordenPharma's Early-Phase Peptide Centre of Excellence

    Product CordenPharma's Early-Phase Peptide Centre of Excellence

    In addition to the largest worldwide capacity of commercial SPPS peptide production up to batch sizes exceeding 400 kg (> 35 Amino Acids), and a yearly capacity of > 2 Metric Tons of Peptide, CordenPharma's multi-pronged approach to becoming the #1 peptide CDMO supplier extends to small-scale capabilities,...
  • Drug Product Services

    Product Drug Product Services

    As your CDMO partner, we provide development and manufacturing services for oral solid dose (OSD), non-sterile liquid and rectal dosage forms, and parenteral dosage forms for all phases of clinical development through commercialization. This broad spectrum of capabilities also allows formulations of highl...

Corden Pharma International GmbH Resources (1)